Vestmark Advisory Solutions’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.6M | Buy |
484,975
+259,669
| +115% | +$12.6M | 0.34% | 66 |
|
|
2025
Q1 | $7.67M | Sell |
225,306
-18,728
| -8% | -$637K | 0.2% | 137 |
|
|
2024
Q4 | $10.8M | Buy |
244,034
+69,937
| +40% | +$3.11M | 0.37% | 57 |
|
|
2024
Q3 | $8.18M | Sell |
174,097
-23,517
| -12% | -$1.1M | 0.3% | 66 |
|
|
2024
Q2 | $10.7M | Sell |
197,614
-51,930
| -21% | -$2.8M | 0.45% | 45 |
|
|
2024
Q1 | $17M | Buy |
249,544
+76,256
| +44% | +$5.2M | 0.73% | 30 |
|
|
2023
Q4 | $10.8M | Buy |
+173,288
| New | +$10.8M | 0.55% | 35 |
|